Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07200115 · ClinicalTrials.gov registry record · NA

RCT of Cervical Ripening Double Ballon Catheter Prior to Dilation and Evacuation.

A NA study of Cervical Preparation Prior to Dilation and Evacuation, sponsored by Yale University.

Recruiting
Registry status
NA
Development phase
50
Enrollment target
1
Study location

NCT07200115 is a NA study of Cervical Preparation Prior to Dilation and Evacuation that is actively recruiting participants, run by Yale University. The registered enrollment target is 50 participants. The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07200115, a NA study of Cervical Preparation Prior to Dilation and Evacuation, is actively recruiting participants, sponsored by Yale University.

RECRUITING
Registry status
NA
Development phase
50 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to determine whether the overnight use of an FDA-cleared CRDB catheter is superior to the use of overnight osmotic dilators as is standard of care cervical preparation for patients presenting for dilation and evacuation (D\&E). The CRDB catheter is an FDA cleared device for cervical dilation prior to labor induction at term. It has not been FDA cleared for cervical dilation in the second-trimester, however, will be used in a similar fashion to labor inductions at term. Our standard of care osmotic dilators (e.g., laminaria, Dilapan-S) are both FDA cleared for cervical dilation prior to labor induction at term or gynecologic procedures requiring cervical dilation.

Interventions

  • DEVICE Cervical Ripening Double Balloon (CRDB) Catheter
  • DEVICE Osmotic Dilators

Study Locations (1)

Connecticut

  • Yale Family Planning Clinic - New Haven

Trial Details

FieldValue
Enrollment Target 50 participants
Start Date 2025-12-03
Est. Completion 2028-09
Phase NA

Sponsor

Yale University

1,492 total trials

What the Registry Record Tells You About NCT07200115

The ClinicalTrials.gov registry entry for NCT07200115 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 50 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Yale University, which has 1,492 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Cervical Preparation Prior to Dilation and Evacuation appearing as the primary indexed condition, and to 2 interventions - of which Cervical Ripening Double Balloon (CRDB) Catheter is the first listed.

NCT07200115 reports 1 study location spanning 1 distinct geographic area - top geographies include Connecticut.

Frequently Asked Questions

What is clinical trial NCT07200115 about?

NCT07200115 is a clinical study titled "RCT of Cervical Ripening Double Ballon Catheter Prior to Dilation and Evacuation.". The purpose of this study is to determine whether the overnight use of an FDA-cleared CRDB catheter is superior to the use of overnight osmotic dilators as is standard of care cervical preparation for patients presenting for dilation and evacuation (D\&E). The CRDB catheter is an FDA cleared device ...

What is the current status of trial NCT07200115?

This trial is currently recruiting. It is a NA study. The enrollment target is 50 participants. The study started on 2025-12-03. Estimated completion is 2028-09.

What conditions does trial NCT07200115 study?

This clinical trial studies the following conditions: Cervical Preparation Prior to Dilation and Evacuation.

What interventions are being tested in trial NCT07200115?

The interventions under investigation include: Cervical Ripening Double Balloon (CRDB) Catheter (DEVICE), Osmotic Dilators (DEVICE).

Who is sponsoring clinical trial NCT07200115?

This trial is sponsored by Yale University, which has 1,492 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT07200115 being conducted?

This trial has 1 study location across Connecticut. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.